Members Trading
6
All-time in Insulet

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Members Trading
6
All-time in Insulet
Buyers vs Sellers
1Buyers/1Sellers
Members buying vs selling · last 90 days
Trades (90d)
3
Disclosed in the last 90 days
Avg Member Return
+1.5%
Top performers, TTM